Oman vs Togo: Previously treated cases tested for RR-/MDR-TB
Oman
100.0%
in 2024
Togo
100.0%
in 2024
Oman rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Oman
- Togo
How they compare
Oman currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 5 times across 16 shared years of data; in 2007 it was Oman ahead.
Oman ranks 1st and Togo ranks 1st of 180 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 12.6% | 87.4% | Oman |
| 2010s | 97.8% | 61.3% | 36.4% | Oman |
| 2020s | 100.0% | 90.2% | 9.8% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Oman or Togo?
- Oman, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Oman and Togo?
- 0.0%, with Oman ahead.
- How many years of comparable data are there for Oman and Togo?
- 16 years are reported by both, from 2007 to 2024.
- How do Oman and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Oman ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.